Mid-term prognostic impact of residual pulmonary congestion assessed by radiographic scoring in patients admitted for worsening heart failure.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
15 08 2019
Historique:
received: 29 05 2018
revised: 03 12 2018
accepted: 25 01 2019
pubmed: 17 2 2019
medline: 24 3 2020
entrez: 17 2 2019
Statut: ppublish

Résumé

Pulmonary congestion is associated with poor prognosis following hospitalization for worsening heart failure (HF), although its quantification and optimal timing during HF hospitalization remains challenging. The aim of this study was to assess the prognostic value of radiographic pulmonary congestion at admission and discharge in patients with worsening HF. Clinical, echocardiographic, laboratory and chest X-ray data of 292 acute decompensated HF patients were retrospectively studied (follow-up 1 year). Lung congestion was blindly scored on chest X-ray performed at admission and discharge using a systematic 6-zone approach. Primary clinical outcome was a composite outcome of re-hospitalization for worsening HF or all cause death. Patients were stratified according to the median of congestion score index (CSI) at both admission (median CSI(A) = 1.33) and discharge (median CSI(D) = 0.33). BNP levels, LVEF and eGFR did not differ between CSI categories. In multivariable Cox regression analysis, discharge CSI (HR for 1-point increase = 1.83 [1.02 to 3.27] p = 0.04) and discharge BNP were significantly associated with the composite outcome whereas NYHA class, physical signs, admission CSI and echocardiographic data were not. Furthermore, discharge CSI significantly increased reclassification on top of clinical covariates (continuous NRI = 19.6% [4.0 to 30.0] p = 0.03 and IDI = 2.2% [0.0 to 7.6] p = 0.046) while discharge BNP did not significantly improve risk reclassification. Residual pulmonary congestion assessed by radiographic scoring predicts poor prognosis beyond physical assessment, echocardiographic parameters and BNP. These findings further support the capital prognostic value of radiographic pulmonary congestion in patients hospitalized for worsening HF.

Identifiants

pubmed: 30770263
pii: S0167-5273(18)33493-4
doi: 10.1016/j.ijcard.2019.01.091
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

91-98

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Masatake Kobayashi (M)

Department of Cardiology, Tokyo Medical University, Tokyo, Japan; Université de Lorraine, INSERM, Centre d'Investigations Cliniques 1433, CHRU de Nancy, Inserm U1116, Nancy, France; INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN network, Nancy, France.

Masataka Watanabe (M)

Department of Cardiology, Tokyo Medical University, Tokyo, Japan.

Stefano Coiro (S)

Division of Cardiology, University of Perugia, School of Medicine, Via S. Andrea delle fratte, Perugia, Italy.

Matthieu Bercker (M)

Department de Cardiologie, CHU de Nancy, Institut Lorrain du coeur et des vaisseaux, Nancy, France.

Yuki Paku (Y)

Department of Cardiology, Tokyo Medical University, Tokyo, Japan.

Yoichi Iwasaki (Y)

Department of Cardiology, Tokyo Medical University, Tokyo, Japan.

Taishiro Chikamori (T)

Department of Cardiology, Tokyo Medical University, Tokyo, Japan.

Akira Yamashina (A)

Department of Cardiology, Tokyo Medical University, Tokyo, Japan.

Kevin Duarte (K)

Université de Lorraine, INSERM, Centre d'Investigations Cliniques 1433, CHRU de Nancy, Inserm U1116, Nancy, France; INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN network, Nancy, France.

João Pedro Ferreira (JP)

Université de Lorraine, INSERM, Centre d'Investigations Cliniques 1433, CHRU de Nancy, Inserm U1116, Nancy, France; Department de Cardiologie, CHU de Nancy, Institut Lorrain du coeur et des vaisseaux, Nancy, France; INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN network, Nancy, France.

Patrick Rossignol (P)

Université de Lorraine, INSERM, Centre d'Investigations Cliniques 1433, CHRU de Nancy, Inserm U1116, Nancy, France; Department de Cardiologie, CHU de Nancy, Institut Lorrain du coeur et des vaisseaux, Nancy, France; INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN network, Nancy, France.

Faiez Zannad (F)

Université de Lorraine, INSERM, Centre d'Investigations Cliniques 1433, CHRU de Nancy, Inserm U1116, Nancy, France; Department de Cardiologie, CHU de Nancy, Institut Lorrain du coeur et des vaisseaux, Nancy, France; INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN network, Nancy, France.

Nicolas Girerd (N)

Université de Lorraine, INSERM, Centre d'Investigations Cliniques 1433, CHRU de Nancy, Inserm U1116, Nancy, France; Department de Cardiologie, CHU de Nancy, Institut Lorrain du coeur et des vaisseaux, Nancy, France; INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN network, Nancy, France. Electronic address: n.girerd@chru-nancy.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH